Terns Pharma Stock (NASDAQ: TERN) stock price, news, charts, stock research, profile.
Open | $7.90 |
Close | $8.22 |
Volume / Avg. | 1.20M / 1.26M |
Day Range | $7.72 - $8.35 |
52 Wk Range | 3.26 - 10.03 |
Market Cap | $533.59M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 4.64% |
Days to Cover | 2.3 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Terns Pharma (NASDAQ:TERN) through any online brokerage.
Other companies in Terns Pharma’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA) and GH Research (NASDAQ:GHRS).
Terns Pharma has a consensus price target of $14.83.
The stock price for Terns Pharma (NASDAQ: TERN) is $8.25 last updated August 23, 2024 at 6:09 PM EDT.
There are no upcoming dividends for Terns Pharma.
Terns Pharma’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Terns Pharma.
Terns Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.